Life Scientist > Biotechnology

Solving the genetics puzzle

07 January, 2019 by Mansi Gandhi

Growing up in Germany, Melanie Bahlo used to record which birds came and visited her bird feeder in the depths of winter. She was around eight years old at the time and loved discovering new things. 


Cannabis-based drug relieves symptoms of motor neuron disease

18 December, 2018

Chemical compounds derived from the cannabis sativa plant, used as an add-on treatment, may help ease symptoms of spasticity in people with motor neuron disease.


Brain-stimulation implant could treat epilepsy patients

04 December, 2018

A tiny device that electrically stimulates the brain could one day be used to treat conditions such as epilepsy and Parkinson's disease — without open-brain surgery.


Roadmap released for regenerative medicine sector

28 November, 2018

MTPConnect's report 'Regenerative Medicine: Opportunities for Australia' provides a roadmap for elevating the sector so it can successfully compete at a global level.


Cannabis compound may benefit children with epilepsy

27 November, 2018

Researchers reviewing studies around the medical use of cannabidiol have found the treatment to be moderately effective in two forms of childhood epilepsy.


Immunotherapy trial for MS shows early positive results

21 November, 2018

A new cellular immunotherapy treatment that targets the Epstein-Barr virus (EBV) has been found to improve multiple sclerosis (MS) symptoms.


Online tool predicts how cells repair broken DNA

19 November, 2018

Researchers have created a machine learning model, inDelphi, that predicts how human and mouse cells respond to CRISPR-induced breaks in DNA.


LogicBio, CMRI partner to develop next-gen viral vectors

19 November, 2018

Genome editing company LogicBio has partnered with the Children's Medical Research Institute to fast-track gene therapy treatments for children with life-threatening genetic liver disease.


AusCann set to launch cannabinoid medicine for chronic pain

15 November, 2018

AusCann's hard-shell capsules will target the estimated 1.9 million Australians who suffer chronic neuropathic pain.


Liver fluke key to chronic wound treatment

08 November, 2018

Researchers have developed a promising new treatment for chronic wounds, utilising a protein isolated from a surprising source — a parasitic Thai liver fluke.


Collaboration to accelerate early-stage drug discovery

07 November, 2018

Biomedical research company BioCurate and pharmaceutical company Novartis have announced they will collaborate on early-stage drug discovery projects.


Plant peptide shows promise in antifungal trial

05 November, 2018

Biotechnology company Hexima has announced promising results for its plant defensin peptide, HXP124, in fungal nail infections.


100% human skin graft developed

01 November, 2018

Researchers have made a skin graft cell culture using only human cells, which could be used to provide safer treatment for severe burns and other skin conditions in the future.


New PBS listings benefit lung cancer, cholesterol patients

30 October, 2018

Two new listings on the Pharmaceutical Benefits Scheme have the potential to extend the lives of Australians with advanced lung cancer and those at risk of a heart attack.


Investigational antibiotic shows promise in UTIs

26 October, 2018

A new investigational antibiotic is proving as effective as the current standard-of-care antibiotic for the treatment of complicated UTIs caused by several multidrug-resistant Gram-negative bacteria.


  • All content Copyright © 2019 Westwick-Farrow Pty Ltd